+++ Einfach investieren ? mit Kapitalschutz oder Teilschutz ? raiffeisenzertifikate.at ? jetzt in Zeichnung +++ -W-
13.01.2016 08:52:21

Earnings Reported After The Bell Jan. 12

(RTTNews) - Here is a quick summary of the earnings reported after the bell on Jan. 12.

Orthofix International N.V. (OFIX)

Q4 preliminary net sales were approximately $105 million. Analysts expected the company to report revenues of $102.43 million for the period.

FY2016 Outlook

Net sales to be between $407 million and $412 million. Analysts expect the company to report revenues of $408.6 million for the period.

***

Aehr Test Systems (AEHR)

Q2 GAAP net loss was $1.0 million, or $0.08 per share, compared to net loss of $2.1 million, or $0.18 per share, in the same quarter a year ago.

Q2 Non-GAAP net loss was $794,000, or $0.06 per share, compared to loss of $1.8 million, or $0.16 per share, in the same quarter a year ago.

Q2 net sales were $4.6 million, up 77% from $2.6 million in the second quarter of last year.

***

CSX Corp. (CSX)

Q4 profit dropped to $466 million or $0.48 per share from $491 million or $0.49 per share last year. Analysts estimated earnings of $0.46 per share for the quarter.

Revenues for the quarter dropped 13 percent to $2.78 billion from $3.19 billion last year. Analysts had a consensus revenue estimate of $2.86 billion for the quarter.

***

Red Robin Gourmet Burgers, Inc., (RRGB)

Red Robin expects Q4 net income to be between $11.1 and $11.7 million and EPS to be between $0.80 and $0.84.

The company expects to report Q4 revenues of approximately $286.3 million.

Analysts expect the company to report net income of $0.76 per share on revenues of $295.93 million for the period.

***

GenMark Diagnostics, Inc. (GNMK)

Q4 preliminary revenue was $13.2 million, an increase of 35% over the prior year period. Analysts expected the company to report revenues of $12.34 million for the period.

***

Glaukos Corporation ( GKOS)

Glaukos estimates fourth quarter net sales will be approximately $20.1 million. Analysts expected the company to report revenues of $20.06 million for the period.

FY2016 Outlook

Net sales for 2016 to be in the range of $90 million to $93 million. Analysts expect the company to report revenues of $90.92 million for the period.

***

Ignite Restaurant Group (IRG)

Q4 preliminary revenue was $93.3 million vs. $97.9 million a year ago. Analysts expected the company to report revenues of $90.95 million for the period.

***

Progress ( PRGS)

Q4 net loss was $9.5 million or $0.19 per share compared to net income of $14.5 million or $0.28 per share in the same quarter last year.

Non-GAAP net income was $27.3 million or $0.53 per share compared to $24.1 million or $0.47 per share in the same quarter last year.

Q4 revenue was $112.7 million compared to $97.9 million in the same quarter a year ago.

Non-GAAP revenue was $115.4 million compared to $97.9 million in the same quarter last year.

Analysts expected the company to report net income of $0.49 per share on revenues of $115.96 million for the period.

Q1 Outlook

Non-GAAP revenue is expected to be between $92 million and $94 million.

Non-GAAP earnings per share is expected to be between $0.27 and $0.29.

Analysts expect the company to report net income of $0.30 per share on revenues of $97.53 million for the period.

FY2016 Outlook

Non-GAAP revenue is expected to be between $427 million and $433 million.

Non-GAAP earnings per share is expected to be between $1.59 and $1.65.

Analysts expect the company to report net income of $1.56 per share on revenues of $427.89 million for the period.

***

TSR, Inc., (TSRI)

Q2 net income attributable to TSR decreased to $120,000 or $0.06 per share from $141,000 or $0.07 per share in the prior year quarter.

Q2 revenue increased 4.5% to $15.1 million from the same quarter last year.

***

Neptune Technologies & Bioressources Inc. (NEPT)

Q3 net loss was $2.93 million versus net income of $74,000 in the prior year.

Q3 revenue was $5.52 million vs. $4.74 million a year ago.

***

Acasti Pharma Inc. (ACST)

Q3 net loss was $2.19 million vs. net earnings of $3.01 million a year ago.

***

Nachrichten zu Credit Suisse (CS)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Credit Suisse (CS)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Credit Suisse (CS) 0,89 0,56% Credit Suisse (CS)